Successful treatment of primary cutaneous localized amyloidosis with a combined therapy of ablative fractionated CO2 laser, topical retinoid, corticosteroids and levovitamin C: Five cases with two-year follow-up.
J Cosmet Laser Ther
; 23(1-2): 16-18, 2021 Feb 17.
Article
em En
| MEDLINE
| ID: mdl-28426270
ABSTRACT
Primary cutaneous localized amyloidosis (PCLA) is a pruritic disorder with no radical cure. We trialed a combined therapy of ablative fractionated CO2 laser, topical retinoid, corticosteroids and levovitamin C on five patients. All patients responded with no intolerant signs. Two-year follow-up visit showed no recurrence. This might be a effective method awaiting more samples for further stronger evidence.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Amiloidose Familiar
/
Terapia a Laser
/
Lasers de Gás
Tipo de estudo:
Observational_studies
/
Prognostic_studies
Limite:
Humans
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article